Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Morphosys ag symbols : TAK save search
Incyte Reports 2023 Fourth Quarter and Year-End Financial Results, Provides 2024 Financial Guidance and Highlights R&D Priorities
Published: 2024-02-13 (Crawled : 19:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.14%
H: 0.35%
C: 0.07%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -3.56%
H: 2.91%
C: -3.34%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: -0.4%
H: 0.23%
C: -0.46%
MGNX | $15.62 -2.8% -2.88% 1M
|
Health Technology
|
| O: -5.25%
H: 2.94%
C: 2.18%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 3.8%
H: 1.1%
C: -1.17%
financial
Incyte to Spotlight More Than 40 Hematology and Oncology Abstracts Including a Plenary Presentation at the ASH Annual Meeting
Published: 2023-11-02 (Crawled : 18:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 1.03%
H: 0.73%
C: 0.58%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.09%
H: 1.03%
C: 0.91%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 1.32%
H: 0.45%
C: -1.19%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 2.22%
H: 0.6%
C: -9.4%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.28%
H: 1.0%
C: -0.46%
presentation meeting
Incyte Reports 2023 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2023-10-31 (Crawled : 00:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 1.05%
H: 0.74%
C: 0.74%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.41%
H: 2.1%
C: 1.11%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 4.23%
H: 0.12%
C: -1.97%
MGNX | $15.62 -2.8% -2.88% 1M
|
Health Technology
|
| O: 0.0%
H: 2.13%
C: 1.16%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.39%
H: 4.09%
C: 3.8%
financial results
Global Antibodies Market Set to Soar, Projected to Reach $524.8 Billion by 2030 with a CAGR of 12.9%
Published: 2023-09-12 (Crawled : 23:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.8%
H: 0.0%
C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.63%
H: 0.5%
C: 0.31%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.05%
H: 0.73%
C: 0.14%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.02%
H: 0.55%
C: -1.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
RARE | News F | $42.37 -2.33% -2.38% 680K
|
Health Technology
|
| O: -0.02%
H: 1.4%
C: -1.07%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.99%
H: 0.0%
C: 0.0%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 0.0%
H: 0.63%
C: -1.98%
IOVA | News M | $11.32 -3.41% -3.53% 5.3M
|
Health Technology
|
| O: -0.34%
H: 0.51%
C: -8.5%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.0%
H: 0.53%
C: -1.76%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.07%
H: 0.53%
C: -1.05%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.37%
H: 0.34%
C: -0.81%
reach global set market
Incyte Reports 2023 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2023-08-01 (Crawled : 15:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -2.23%
H: 2.28%
C: 1.34%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
REPL | $6.47 -7.17% -7.73% 870K
|
Health Technology
|
| O: 2.63%
H: 1.14%
C: -2.65%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: -0.14%
H: 4.77%
C: 4.77%
MGNX | $15.62 -2.8% -2.88% 1M
|
Health Technology
|
| O: 0.0%
H: 4.19%
C: 2.31%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 2.75%
H: 0.44%
C: -2.72%
financial results
Incyte Reports 2023 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2023-05-02 (Crawled : 12:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.42%
H: 0.48%
C: 0.3%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.63%
H: 0.15%
C: -1.78%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: -3.15%
MGNX | $15.62 -2.8% -2.88% 1M
|
Health Technology
|
| O: -1.62%
H: 2.47%
C: -6.58%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -9.64%
H: 5.99%
C: 2.76%
financial results
Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance and Updates on Key Clinical Programs
Published: 2023-02-07 (Crawled : 13:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.27%
H: 0.0%
C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.13%
H: 1.01%
C: 0.89%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.29%
H: 0.86%
C: 0.72%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.19%
H: 1.15%
C: -2.27%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -0.59%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -1.02%
H: 0.29%
C: -3.04%
financial
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.68%
H: 1.05%
C: -0.23%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.47%
H: 0.09%
C: -0.55%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 1.07%
H: 2.51%
C: -0.11%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 3.1%
H: 1.8%
C: -0.6%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 1.59%
H: 7.26%
C: 1.89%
financial results
Incyte Reports 2022 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-08-02 (Crawled : 12:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -2.62%
H: 0.0%
C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -1.33%
H: 0.78%
C: -1.06%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.02%
H: 0.39%
C: -0.64%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.32%
H: 5.09%
C: 3.9%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: -3.37%
H: 3.3%
C: 0.92%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -4.39%
H: 0.2%
C: -1.92%
results
Data from Incyte’s Robust and Progressing Oncology Portfolio to be Presented at 2022 EHA Annual Meeting
Published: 2022-05-26 (Crawled : 11:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.17%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 3.5%
H: 2.14%
C: 0.19%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 1.26%
H: 0.95%
C: -1.13%
Incyte Reports 2021 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2021-11-02 (Crawled : 12:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.49%
H: 0.56%
C: -0.07%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.3%
H: 0.15%
C: -0.4%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 2.7%
H: 1.01%
C: 0.85%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 3.75%
H: 1.22%
C: 1.22%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -1.93%
H: 0.19%
C: -3.14%
financial results results
Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: -0.6%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.3%
H: 0.17%
C: 0.17%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 0.55%
H: 1.32%
C: 1.03%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: -2.43%
H: 0.88%
C: 0.44%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.7%
H: 0.31%
C: 0.04%
financial results results
Incyte Reports 2021 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: -1.25%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.82%
H: 0.28%
C: -0.06%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: -5.61%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: -4.71%
H: 0.33%
C: -2.65%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -2.37%
H: 2.04%
C: -2.95%
financial results results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.